New medtech company Carvolix created as Affluent Medical acquires Caranx Medical and Artedrone
February 16, 2026Research and Development Cardiology, Carvolix
Carvolix (formerly Affluent Medical), a commercial and clinical-stage biotechnology company developing AI-powered mini-robots and biomimetic implants, has completed the acquisition …
Qlaris Bio appoints Robert Warner to board of directors
February 16, 2026Qlaris Bio
Qlaris Bio has appointed Robert Warner to its board of directors. Warner brings significant experience in life sciences leadership to …
Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation
February 12, 2026Research and Development Cardiology, Rhythm AI, atrial fibrillation
Rhythm AI, a UK-based company specialising in atrial fibrillation procedures, has announced that its STAR Apollo Mapping System has received …
iOrganBio appoints Karol Jarzabek as Chief Operating Officer
February 12, 2026Manufacturing and Production iOrganBio
iOrganBio has announced the appointment of Karol Jarzabek as Chief Operating Officer (COO). Jarzabek specialises in operational management and business …
Ensera Design expands UK leadership team with new senior appointments
February 11, 2026Business Services, Consultancy Ensera Design
Ensera Design, a healthcare product innovation consultancy, has announced the expansion of its UK leadership team with multiple new appointments. …
Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine
February 11, 2026Research and Development Infinitopes, Oncology
Infinitopes, a clinical stage biotechnology company specialising in oncology, has announced the receipt of an additional $15.4m in seed funding, …
Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer
February 10, 2026Angelini Pharma
Angelini Pharma, the pharmaceutical branch of Angelini Industries, has announced the appointment of Roberto Scrivo as Chief of External Affairs, …
Hongene Biotech receives Gates Foundation grant to drive mRNA vaccine production
February 10, 2026Manufacturing and Production Hongene Biotech, mRNA vaccine
Hongene Biotech, a contract development and manufacturing organisation (CDMO) and ribonucleic acid (RNA) technology provider, has announced the receipt of …
BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer
February 5, 2026Research and Development BMS, Scottish Medicines Consortium, colorectal cancer, oncology
Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination with Yervoy (ipilimumab), by the …
AstronauTx appoints Adam Rosenberg as Chair of the Board
February 5, 2026AstronauTx, chair of the board
AstronauTx has announced the appointment of Adam Rosenberg as Chair of its Board of Directors. Rosenberg’s leadership experience includes holding …
Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer
February 4, 2026Research and Development Astellas Pharma, Scottish Medicines Consortium, Vyloy, gastric cancer, oncology
Astellas Pharma, a pharmaceutical company creating medicines to address unmet medical needs, has announced that Vyloy (zolbetuximab), in combination with …
Angelini Pharma appoints Sergio Marullo di Condojanni as CEO
February 4, 2026Angelini Pharma, CEO
Angelini Pharma, a branch of Angelini Industries, has announced the appointment of Sergio Marullo di Condojanni as CEO. Marullo di …
QV Bioelectronics secures £4.5m in funding for brain cancer therapy development
February 3, 2026Research and Development Oncology, QV Bioelectronics, glioblastoma
QV Bioelectronics, a medtech business specialising in implants for cancer treatment, has announced that it has received £4.5m in funding …
Alvotech appoints Lisa Graver as CEO
February 3, 2026Alvotech, CEO
Alvotech has announced the appointment of Lisa Graver as CEO, following the retirement of Róbert Wessman. Wessman served as Chairman …
HonorHealth Research Institute announces first patient dosed with new stroke treatment
February 2, 2026Research and Development HonorHealth Research Institute, Neurology, ischemic stroke
HonorHealth Research Institute, a research institution collaborating with a wide range of experts to produce new treatments and devices, has …
Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK
February 2, 2026Accord healthcare, Associate Vice President, Country Head
Accord Healthcare has announced the appointment of Paul Burden as Associate Vice President and Country Head of Accord UK. Burden …
Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases
January 30, 2026Medical Communications United Nations, WHO, healthcare access, mental health, noncommunicable diseases, primary care
The 80th United Nations General Assembly (UNGA) has adopted the political declaration to combat mental health challenges and noncommunicable diseases …
Rare diseases – spinal muscular atrophy
January 30, 2026Medical Communications gene therapy, medical communications, muscle and motor function, muscle weakness, rare diseases, sma
Spinal muscular atrophy (SMA) is a rare disease characterised by voluntary muscle weakness that can lead to difficulties in activities …
Could targeting the molecular causes of infertility finally transform IVF success rates?
January 29, 2026Medical Communications, Research and Development Biotechnology, IVF, assisted reproductive technology, fertility therapeutics, infertility
By Dr Jordan Abdi Over the past two decades, demand for IVF has risen sharply as parenthood is increasingly delayed …
Digital mental health technologies – a valuable tool in supporting people with depression and anxiety
January 29, 2026Medical Communications MHRA, NHS, NICE, Wellcome, digital technologies, medical communications, mental health
The potential benefits of digital mental health technology for managing depression, anxiety and stress, together with other forms of care, …
